Dalton Lohsandt, MD
Family Medicine · Fayette, MONPI 1861018210
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $209, 9.4 times the $22 reported in 2023. That places this record below the midpoint for family medicine clinicians in MO, where the typical reported total is $366.
Across 12 payments — averaging $23.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exact Sciences$66
- Medtronic$55
- Sanofi$41
- AbbVie$35
- Nevro Corp.$22
- Regeneron Healthcare Solutions, Inc.$22
- plus $38 from 2 others
What the payments were for
- Food & beverage$278100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exact Sciences | 3 | $66 |
| Medtronic | 1 | $55 |
| Sanofi | 2 | $41 |
| AbbVie | 2 | $35 |
| Nevro Corp. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Novo Nordisk | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
How this compares
$278 in reported general payments places this provider in the 45th percentile of 2,203 family medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 21 | $217 |
| Atorvastatin Calcium | 21 | $162 |
| Spironolactone | 13 | $155 |
| Amlodipine Besylate | 26 | $77 |
| Lisinopril | 16 | $62 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Fayette
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
- Christine MooreRaymore$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.